RankingsPricing
  1. US-listed companies
  2. DEXCOM INC
  3. Financials
  4. EBITDA

DEXCOM INCDXCM

Market cap
$25.8B
P/E ratio
SummaryFinancials
Period EndEBITDA (Million USD)YoY (%)
Dec 31, 2024818+4.34%
Dec 31, 2023784+43.25%
Dec 31, 2022547+48.75%
Dec 31, 2021368+0.33%
Dec 31, 2020367+91.94%
Dec 31, 2019191-221.50%
Dec 31, 2018-157+495.45%
Dec 31, 2017-26-46.01%
Dec 31, 2016-49+5.62%
Dec 31, 2015-46+253.44%
Dec 31, 2014-13-40.18%
Dec 31, 2013-22-55.40%
Dec 31, 2012-49+19.51%
Dec 31, 2011-41

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)